| Literature DB >> 34319949 |
Katharina Dendl1, Andreas Merkel1, Clemens Kratochwil1, Peter L Choyke2, Christian Kleist1, Jens Cardinale, Uwe Haberkorn, Frederik L Giesel.
Abstract
ABSTRACT: Prostate-specific membrane antigen (PSMA) PET/CT is a highly reliable nuclear tracer for diagnostic imaging of prostate cancer. However, PSMA is also expressed by some nonprostatic tissues such as benign tumors, inflammatory processes, and malignant neoplasms. This case presents a patient with prostate cancer and follicular lymphoma undergoing PSMA PET/CT. Remarkably, both tumor entities were clearly detected in the scan. Yet, the 2 malignancies demonstrated rather different ranges in terms of SUVmax uptake values and therefore still enabled precise and accurate discrimination of prostate cancer and follicular lymphoma.Entities:
Mesh:
Substances:
Year: 2022 PMID: 34319949 DOI: 10.1097/RLU.0000000000003828
Source DB: PubMed Journal: Clin Nucl Med ISSN: 0363-9762 Impact factor: 7.794